🔎 Trials Near Me

Beranda › Glioma › California › San Francisco

Uji klinis Glioma di San Francisco, CA

14 studi untuk Glioma mencari peserta di lokasi sekitar San Francisco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Menerima pesertaFase 1/2
  • Research Site, San Francisco
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05417594

MCT for the Harvard/UCSF ROBIN Center

Menerima peserta
  • University of California, San Francisco, San Francisco
Semua usia · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06000787

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • UCSF Medical Center-Mission Bay, San Francisco
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • University of California, San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06594315

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Menerima pesertaFase 3
  • University of California, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Menerima pesertaFase 1
  • University of California, San Francisco, San Francisco
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT04485559

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Menerima pesertaFase 2
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Imaging of Solid Tumors Using 18F-TRX

Menerima pesertaFase 1
  • University of California, San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06942104

Hyperpolarized Imaging in Diagnosing Participants With Glioma

Menerima pesertaFase 1
  • University of California, San Francisco, San Francisco
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT03739411

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

Menerima pesertaFase 1
  • University of California, San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT04540107

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Menerima pesertaFase 1
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Menerima pesertaFase 1/2
  • University of California at San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Menerima pesertaFase 1/2
  • University of California, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT06504381

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Menerima pesertaStudi observasional
  • University of California, San Francisco (UCSF), San Francisco
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Feb 2024 · NCT06118723

Uji klinis Glioma di kota lain

Studi lain di San Francisco

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.